$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
Data on the efficacy of the targeted drug cabozantinib in the treatment of RET rearranged lung cancer
2025-10-19 11:44:20
Check Details
Increase the reimbursement ratio? The latest interpretation of Jitai Rui’s 2021 medical insurance reimbursement policy
2025-10-19 11:44:20
Check Details
Can Xekori (crizotinib capsules) be reimbursed by medical insurance? What is the latest reimbursement rate?
2025-10-19 11:44:20
Check Details
Analysis of the efficacy and adverse reactions of cabozantinib in the treatment of RET rearranged lung cancer
2025-10-19 11:44:20
Check Details
How much does a box of lung cancer targeted drug gefitinib cost? Where to buy and save money?
2025-10-19 11:44:20
Check Details
How much does a course of nivolumab injection cost for a patient?
2025-10-19 11:44:20
Check Details
[Hurry up and collect] What is the price of Giteri before it is included in medical insurance? How much does a box of Giteri cost?
2025-10-19 11:44:20
Check Details
When is the best time to take gefitinib? What should I pay attention to when taking gefitinib?
2025-10-19 11:44:20
Check Details
[Clinical Study] How effective is crizotinib in patients with ROS1-rearranged non-small cell lung cancer?
2025-10-19 11:44:20
Check Details
How long is a course of nivolumab treatment?
2025-10-19 11:44:20
Check Details
Can nivolumab be used to treat small cell lung cancer?
2025-10-19 11:44:20
Check Details
Heavy! U.S. FDA grants Xalkori (crizotinib) breakthrough drug status
2025-10-19 11:44:20
Check Details
1
2
...
3902
3903
3904
3905
3906
3907
3908
...
4152
4153
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
2
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI
3
Pimitespib Storage Guidelines: Temperature, Humidity & Light Control for Home Use
4
Cemiplimab (Libtayo) Drug Information
5
Mirvetuximab Soravtansine (Elahere): FRα-Targeted ADC for Platinum-Resistant Ovarian Cancer
6
The Cornerstone Therapy for Adrenocortical Carcinoma and Global Guidelines Update
7
Trodelvy® (Sacituzumab Govitecan-hziy): A Life-Changing ADC for Advanced Cancers
8
A Revolutionary Targeted Therapy for Hematological Malignancies
9
A New Option for Advanced Renal Cell Carcinoma Treatment
10
Trametinib (Mekinist): Precision MEK1/2 Inhibition Transforming Cancer Care Short Description:
11
Pirtobrutinib: A Novel BTK Inhibitor Offering Hope for Hematologic Cancer Patients Short Description:
12
Sacituzumab Govitecan: Trop-2 Targeted ADC Clinical Medication Guide